Detalhe da pesquisa
1.
Effectiveness, Toxicity, and Survival Predictors of Regorafenib in Metastatic Colorectal Cancer: A Multicenter Study of Routinely Collected Data.
Oncology (Williston Park)
; 36(12): 732-738, 2022 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36548097